首页> 外文期刊>Case Reports in Nephrology and Dialysis >Sodium Thiosulfate: An Emerging Treatment for Calciphylaxis in Dialysis Patients
【24h】

Sodium Thiosulfate: An Emerging Treatment for Calciphylaxis in Dialysis Patients

机译:硫代硫酸钠:一种针对透析患者进行钙盐合成的新兴疗法

获取原文
           

摘要

Calciphylaxis is a rare but life-threatening complication seen in dialysis patients. We report a case with calciphylaxis and severe secondary hyperparathyroidism. Sodium thiosulfate (STS) was used for treatment in this case. The painful skin ulcers improved significantly soon after treatment, with a slight reduction in the calcium-phosphorus product. Total parathyroidectomy was carried out 6 months after the STS therapy, which successfully solved hyperparathyroidism and the high calcium-phosphorus profiles. Until now, no recurrence of calciphylaxis has been observed during the more than 7 years of follow-up. STS, as a chelating agent for calcium and iron, is an emerging treatment option for calciphylaxis; however, the mechanisms of STS in treating calciphylaxis are not clear. Our case demonstrates that STS treatment did not work through normalizing calcium-phosphorus profiles, although to optimize hyperparathyroidism and to control calcium and phosphorus levels is clearly part of the general treatment of calciphylaxis. The literature on STS treatment for calciphylaxis in dialysis patients was also reviewed.
机译:降钙素是在透析患者中​​罕见但危及生命的并发症。我们报告一例患有钙减少和严重继发性甲状旁腺功能亢进症。在这种情况下,使用硫代硫酸钠(STS)进行治疗。治疗后不久,疼痛的皮肤溃疡明显改善,钙磷产物略有减少。 STS治疗后6个月进行了全甲状旁腺切除术,成功地解决了甲状旁腺功能亢进和高钙磷水平。到现在为止,在超过7年的随访期间,尚未观察到降钙素的复发。 STS作为钙和铁的螯合剂,是预防钙化的新兴治疗方法。但是,STS治疗钙化反应的机制尚不清楚。我们的病例证明,尽管优化甲状旁腺功能亢进症和控制钙和磷水平显然是钙化疗法常规治疗的一部分,但STS治疗无法通过使钙磷分布正常化而起作用。还综述了有关STS治疗透析患者钙化的文献。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号